NBIX ▲ +0.0% - Neurocrine Biosciences, Inc.
$NBIX - Neurocrine Biosciences Presents Real-World Evidence Mapping the Lifelong, Evolving Impact of Classic Congenital Adrenal Hyperplasia
16-OCT-2026 08:30 AM ET
Share this post
More filings for $NBIX
NBIX ▼ -0.4% - Neurocrine Biosciences, Inc.Nov 5, 2026NBIX ▲ +13.3% - Neurocrine Biosciences, Inc.Nov 3, 2026NBIX ▲ +9.5% - Neurocrine Biosciences, Inc.Nov 2, 2026NBIX ▼ -1.2% - Neurocrine Biosciences, Inc.Nov 2, 2026NBIX - Neurocrine Biosciences, Inc. - SEC Filing Update (30-OCT-2026) | ThinkSabio - Stocks SimplifiedOct 30, 2026NBIX ▼ -0.3% - Neurocrine Biosciences, Inc.Oct 30, 2026
View full $NBIX filing history →💬 Comments
Loading comments…
Leave a comment